IV Hydration Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service (Immune Booster, Energy Booster, Skin Care, Others), By Component (Emergency Healthcare, Routine Healthcare), By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others), By Region and Competition, 2020-2030F

May 2025 | 180 pages | ID: IC4F041F9CAEEN
TechSci Research

US$ 4,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Market Overview

The Global IV Hydration Therapy Market was valued at USD 2.51 billion in 2024 and is projected treach USD 3.94 billion by 2030, growing at a CAGR of 7.80%. This growth is primarily attributed tthe increasing incidence of chronic illnesses, rising surgical volumes, and the growing number of intravenous drug approvals worldwide. The expansion of IV therapy clinics is alsenhancing companies’ geographic presence, thereby boosting market penetration. Additionally, the effectiveness and quick response time of IV therapy make it an ideal solution for treating malnutrition and delivering essential nutrients, especially for patients unable tconsume food orally. The aging population, with a heightened need for intravenous nutritional support, is further fueling market expansion. A notable example includes Sameday Health’s launch of the Inner Beauty IV drip in July 2022, which emphasizes wellness and aesthetic benefits such as improved skin, nails, and hair health, highlighting the increasing consumer focus on preventive and lifestyle healthcare.

Key Market Drivers

Rising Prevalence of Chronic Diseases and Dehydration-Related Conditions

The growing global burden of chronic illnesses and dehydration-related issues significantly drives the demand for IV hydration therapy. Conditions like diabetes, kidney disease, and digestive disorders often result in fluid imbalances, making intravenous hydration essential for effective treatment. According tthe World Health Organization, chronic diseases account for 71% of all global deaths, indicating a broad base of potential IV therapy patients. Dehydration is particularly prevalent among elderly individuals, athletes, and those under stress. The CDC reports that older adults are especially susceptible due treduced thirst sensitivity and coexisting health conditions, which reinforces the importance of accessible and reliable hydration solutions through IV therapy.

Key Market Challenges

Regulatory and Safety Concerns

IV hydration therapy faces notable regulatory and safety obstacles that could impede market growth. A lack of consistent regulatory frameworks across different regions raises concerns about the quality and professionalism of services offered. In some areas, IV treatments are administered by staff lacking proper medical training, posing risks such as infections, vein inflammation, or electrolyte imbalances. Furthermore, the U.S. FDA has not approved IV hydration therapy for general wellness applications, underlining the need for more comprehensive clinical research testablish safety and efficacy. Addressing these challenges requires the implementation of standardized protocols and oversight tmaintain patient safety and public trust.

Key Market Trends

Technological Advancements and Service Innovations

Innovations in technology are reshaping the IV hydration therapy market by making treatments more accessible and patient-centric. Portable infusion systems and integration with telemedicine platforms have enabled home-based treatments, broadening the reach of IV therapy. Additionally, clinics are increasingly offering personalized IV solutions tailored tspecific wellness goals, such as immune support, detoxification, and anti-aging. This trend toward customization reflects the rising consumer demand for individualized healthcare experiences, helping drive adoption across various patient segments.

Key Market Players
  • Core IV Therapy, LLC
  • Cryojuvenate UK
  • B. Braun SE
  • Pfizer, Inc.
  • JW Life Science
  • Amanta Healthcare
  • Vifor Pharma Management Ltd
  • Otsuka Pharmaceutical Co., Ltd.
  • Baxter
  • ICU Medical, Inc.
Report Scope:

In this report, the Global IV Hydration Therapy Market has been segmented intthe following categories, in addition tthe industry trends which have alsbeen detailed below:
  • IV Hydration Therapy Market, By Service:
  • Immune Booster
  • Energy Booster
  • Skin Care
  • Others
  • IV Hydration Therapy Market, By Component:
  • Emergency Healthcare
  • Routine Healthcare
  • IV Hydration Therapy Market, By End User:
  • Hospitals & Clinics
  • Wellness Centers & Spa
  • Home Healthcare
  • Others
  • IV Hydration Therapy Market, By Region:
  • North America
  • United States
  • Mexico
  • Canada
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global IV Hydration Therapy Market.

Available Customizations:

Global IV Hydration Therapy Market report with the given market data, TechSci Research offers customizations according ta company's specific needs. The following customization options are available for the report:

Company Information
    • Detailed analysis and profiling of additional market players (up tfive).
1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL IV HYDRATION THERAPY MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  5.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  5.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  5.2.5. By Company (2024)
5.3. Market Map
  5.3.1 By Service
  5.3.2 By Component
  5.3.3 By End Users
  5.3.4 By Region

6. NORTH AMERICA IV HYDRATION THERAPY MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  6.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  6.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States IV Hydration Therapy Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Service
      6.3.1.2.2. By Component
      6.3.1.2.3. By End User
  6.3.2. Canada IV Hydration Therapy Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Service
      6.3.2.2.2. By Component
      6.3.2.2.3. By End User
  6.3.3. Mexico IV Hydration Therapy Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Service
      6.3.3.2.2. By Component
      6.3.3.2.3. By End User

7. EUROPE IV HYDRATION THERAPY MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  7.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  7.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. France IV Hydration Therapy Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Service
      7.3.1.2.2. By Component
      7.3.1.2.3. By End User
  7.3.2. Germany IV Hydration Therapy Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Service
      7.3.2.2.2. By Component
      7.3.2.2.3. By End User
  7.3.3. United Kingdom IV Hydration Therapy Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Service
      7.3.3.2.2. By Component
      7.3.3.2.3. By End User
  7.3.4. Italy IV Hydration Therapy Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Service
      7.3.4.2.2. By Component
      7.3.4.2.3. By End User
  7.3.5. Spain IV Hydration Therapy Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Service
      7.3.5.2.2. By Component
      7.3.5.2.3. By End User

8. ASIA-PACIFIC IV HYDRATION THERAPY MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  8.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  8.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
  8.3.1. China IV Hydration Therapy Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Service
      8.3.1.2.2. By Component
      8.3.1.2.3. By End User
  8.3.2. India IV Hydration Therapy Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Service
      8.3.2.2.2. By Component
      8.3.2.2.3. By End User
  8.3.3. Japan IV Hydration Therapy Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Service
      8.3.3.2.2. By Component
      8.3.3.2.3. By End User
  8.3.4. South Korea IV Hydration Therapy Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Service
      8.3.4.2.2. By Component
      8.3.4.2.3. By End User
  8.3.5. Australia IV Hydration Therapy Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Service
      8.3.5.2.2. By Component
      8.3.5.2.3. By End User

9. SOUTH AMERICA IV HYDRATION THERAPY MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  9.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  9.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  9.2.4. By Country
9.3. South America: Country Analysis
  9.3.1. Brazil IV Hydration Therapy Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Service
      9.3.1.2.2. By Component
      9.3.1.2.3. By End User
  9.3.2. Argentina IV Hydration Therapy Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Service
      9.3.2.2.2. By Component
      9.3.2.2.3. By End User
  9.3.3. Colombia IV Hydration Therapy Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Service
      9.3.3.2.2. By Component
      9.3.3.2.3. By End User

10. MIDDLE EAST AND AFRICA IV HYDRATION THERAPY MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  10.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  10.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  10.2.4. By Country
10.3. MEA: Country Analysis
  10.3.1. South Africa IV Hydration Therapy Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Service
      10.3.1.2.2. By Component
      10.3.1.2.3. By End User
  10.3.2. Saudi Arabia IV Hydration Therapy Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Service
      10.3.2.2.2. By Component
      10.3.2.2.3. By End User
  10.3.3. UAE IV Hydration Therapy Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Service
      10.3.3.2.2. By Component
      10.3.3.2.3. By End User

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. GLOBAL IV HYDRATION THERAPY MARKET: SWOT ANALYSIS

14. PORTER’S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Core IV Therapy, LLC
  15.1.1. Business Overview
  15.1.2. Company Snapshot
  15.1.3. Products & Services
  15.1.4. Financials (As Reported)
  15.1.5. Recent Developments
  15.1.6. Key Personnel Details
  15.1.7. SWOT Analysis
15.2. Cryojuvenate UK
15.3. B. Braun SE
15.4. Pfizer, Inc.
15.5. JW Life Science
15.6. Amanta Healthcare
15.7. Vifor Pharma Management Ltd
15.8. Otsuka Pharmaceutical Co., Ltd.
15.9. Baxter
15.10. ICU Medical, Inc.

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER


More Publications